Telomir Pharmaceuticals (TELO) Earnings Date & Reports

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TELO is expected to report earnings to fall 28.57% to -5 cents per share on September 03

Telomir Pharmaceuticals TELO Stock Earnings Reports

Q2'25

Est.

$-0.05

Q1'25

Missed

by $0.01

The last earnings report on May 28 showed earnings per share of -7 cents, missing the estimate of -5 cents. With 127.63K shares outstanding, the current market capitalization sits at 48.15M.

View a ticker or compare two or three

Compare

TELO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For TELO
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TELO showed earnings on May 28, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

855 N Wolfe Street

Phone

+1 737 289-0835

Employees

Web

https://www.telomirpharma.com